Immunobridging Study: Immunogenicity and Safety of Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) Vaccine as Heterologue Booster in Adolescent Subjects in Indonesia
Tahapan Penelitian : Complete
Sponsor:
BKPK Kemenkes
Mitra Pelaksana:
PT Biotis Pharmaceutical Indonesia, Universitas Airlangga
No Registry
INA-6D5D9F9
Tanggal Input Registry : 19-07-2024
Tracking Information | |
---|---|
Tanggal Antisipasi Studi | 01-01-2023 |
Outcome Primer | not specified |
Outcome Skunder | |
Descriptive Information | |
Judul Penelitian Popular | Immunobridging Study: Immunogenicity and Safety of Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) Vaccine as Heterologue Booster in Adolescent Subjects in Indonesia |
Judul Penelitian Ilmiah | Immunobridging Study: Immunogenicity and Safety of Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) Vaccine as Heterologue Booster in Adolescent Subjects in Indonesia |
Jenis Penelitian | Interventional |
Intervensi | Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) Vaccine |
Jumlah Subyek Penelitian | 5 |
Recruitment Information | |
Eligibility Criteria | Inclusion Criteria: not specifiedExclusion Criteria: not specified |
Administrative Information | |
Nomor Persetujuan Etik | not specified |
Nomor Persetujuan Material Transfer Agreement | Not applicable |
Nomor Persetujuan Pelaksanaan Uji Klinik | PPUK/PPUB number |
Other Study ID Numbers | |
Contact Person | not specified |